| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | -6.37% | +0.67% | -7.04% | -10.13% | — |
| 14d | 4 | +25.00% | +21.53% | +0.10% | +21.43% | +14.85% | — |
| 30d | 4 | +0.00% | +25.39% | -0.53% | +25.92% | +24.44% | — |
| 60d | 4 | +50.00% | +14.85% | -7.87% | +22.72% | +19.88% | — |
| 90d | 4 | +50.00% | +10.01% | -3.50% | +13.51% | +10.03% | — |
| 180d | 4(2 pending) | +100.00% | -31.80% | +4.45% | -36.24% | -36.24% | — |
| 1y | 4(2 pending) | +50.00% | -4.43% | +14.85% | -19.27% | -19.27% | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 203,307 | — | — | 203,307 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE EVP of R&D | 35,700 | $1.77 | $63.2K | 581,166 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 718,763 | — | — | 718,763 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE EVP of R&D | 26,269 | $1.56 | $41.0K | 616,866 | Jan 21, 2026 | Jan 23, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE EVP of R&D | 18,832 | $1.70 | $32.0K | 643,135 | Feb 3, 2025 | Feb 5, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 614,844 | — | — | 614,844 | Jan 24, 2025 | Jan 28, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 173,913 | — | — | 661,967 | Jan 24, 2025 | Jan 28, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE EVP of R&D | 27,199 | $1.78 | $48.4K | 488,054 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,000 | — | — | 515,253 | Jan 25, 2024 | Jan 31, 2024 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 494,949 | — | — | 494,949 | Jan 25, 2024 | Jan 31, 2024 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE EVP of R&D | 24,690 | $3.17 | $78.4K | 375,253 | Jan 22, 2024 | Jan 22, 2024 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 148,035 | — | — | 399,943 | Mar 22, 2023 | Mar 24, 2023 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 251,908 | — | — | 251,908 | Jan 20, 2023 | Jan 24, 2023 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 873,015 | — | — | 873,015 | Jan 20, 2023 | Jan 24, 2023 ↗ | View → |
| TIL INSTIL BIO, INC. | PURCHASEGRANT Stock grant | 245,000 | $8.62 | $2.11M | 245,000 | Mar 4, 2022 | Mar 7, 2022 ↗ | View → |
| TIL INSTIL BIO, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 240,000 | Oct 7, 2021 | Oct 8, 2021 ↗ | View → |
| TIL INSTIL BIO, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Sep 10, 2021 | Sep 13, 2021 ↗ | View → |
| TIL INSTIL BIO, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | May 11, 2021 | May 13, 2021 ↗ | View → |
| TIL INSTIL BIO, INC. | PURCHASEGRANT Stock grant | 240,000 | — | — | 240,000 | Mar 18, 2021 | Mar 22, 2021 ↗ | View → |